Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash


AGORACOM WIRE .... WEEKEND EDITION

TOP STORY .... AGORACOM Launches GraphiteStocksBlog.com

We're proud to announce the launch of GraphiteStocksBlog.com a website dedicated to the needs of investors and companies in the fast growing Graphite industry.

INAUGURAL GRAPHITE SPONSORS

 

AGORACOM INTERVIEWS ERIC SPROTT: Eric Discusses UC Resources $1.5M Investment INTO Sprott + Current And Future Silver Path

Message: 10-Q is out

Generic_profile
Rank: [?]
Mail Room
Points: [?]
203
Rating: [?]
Votes: 8 Score: 3.6
  • Currently 3.6/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

10-Q is out

posted on May 15, 09 04:12AM

10-Q has been released so I am sure it will receive scrutiny. Of interest is the capital requirements for the balance of this year:



Capital Requirements

Biocurex anticipates that its capital requirements for the twelve months
ending December 31, 2009 will be as follows:


Business Development $ 200,000
Research, Development and production - Invitro
diagnostics (rapid tests, blood tests, histology
tests, production of ASR's) 700,000
Payment of Outstanding Liabilities 80,000
General and Administrative Expenses 450,000
Marketing and Investor Communications 600,000
Payment of Principal on Convertible Notes 1,200,000
Payment of Interest on Convertible Notes 198,660
------------
$3,428,660
============

New Message

Please login to post a reply

AGORACOM Quick Tips

Start A New HUB. Control. Quality. Refreshing. ... Start One Now
Watch
Today's Show
in 00:00:000

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote